Similar to what was described in pancreatic cancer, Midkine-mediated upregulation of Notch1, responsible for Notch2 upregulation, was also reported as a resistance mechanism for biliary tract cancer [585]. This evidence concerns the gene NOTCH1 and pancreatic neoplasm.